The outcomes of emergency hospital admissions with non-malignant upper gastrointestinal bleeding in England between 2003 and 2015

Abstract

Background Upper gastrointestinal bleeding (UGIB) is a common medical emergency with significant mortality. Despite developments in endoscopic and clinical management, only minor improvements in outcomes have been reported.

Methods This was a retrospective cohort study of patients with non-malignant UGIB emergency admissions in England between 2003 and 2015, using Hospital Episode Statistics. Multilevel logistic regression analysis examined the associations with mortality.

Results 242 796 patients with an UGIB admission were identified (58.8 % men; median age 70 [interquartile range (IQR) 53 – 81]). Between 2003 and 2015, falls occurred in both 30-day mortality (7.5 % to 7.0 %; P < 0.001) and age-standardized mortality (odds ratio (OR) 0.74, 95 % confidence interval [CI] 0.69 – 0.80; P < 0.001), including from variceal bleeding (OR 0.63, 95 %CI 0.45 – 0.87; P < 0.005). Increasing co-morbidity (Charlson score > 5, OR 2.94, 95 %CI 2.85 – 3.04; P < 0.001), older age (> 83 years, OR 6.50, 95 %CI 6.09 – 6.94; P < 0.001), variceal bleeding (OR 2.03, 95 %CI 1.89 – 2.18; P < 0.001), and a weekend admission (Sunday, OR 1.18, 95 %CI 1.12 – 1.23; P < 0.001) were associated with 30-day mortality. Of deaths at 30 days, 8.9 % were from ischemic heart disease (IHD) and the cardiovascular age-standardized mortality rate following UGIB was high (IHD deaths within 1 year, 1188.4 [95 %CI 1036.8 – 1353.8] per 100 000 men in 2003).

Conclusions Between 2003 and 2015, 30-day mortality among emergency admissions with non-malignant UGIB fell by 0.5 % to 7.0 %. Mortality was higher among UGIB admissions at the weekend, with important implications for service provision. Patients with UGIB had a much greater risk of subsequently dying from cardiovascular disease and addressing this risk is a key management step in UGIB.

Publication History

Received: 21 April 2020

Accepted after revision: 16 November 2020

Publication Date:
18 February 2021 (online)

• References

• 1 Blatchford O, Davidson LA, Murray WR. et al. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997; 315: 510-514
• 2 Rockall TA, Logan RFA, Devlin HB. et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995; 311: 222-226
• 3 Hearnshaw SA, Logan RFA, Lowe D. et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011; 60: 1327-1335
• 4 Crooks C, Card T, West J. Reductions in 28-day mortality following hospital admission for upper gastrointestinal hemorrhage. Gastroenterology 2011; 141: 62-70
• 5 Ananthakrishnan AN, McGinley EL, Saeian K. Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. Clin Gastroenterol Hepatol 2009; 7: 296-302e1
• 6 Shaheen AAM, Kaplan GG, Myers RP. Weekend versus weekday admission and mortality from gastrointestinal hemorrhage caused by peptic ulcer disease. Clin Gastroenterol Hepatol 2009; 7: 303-310
• 7 Jairath V, Kahan BC, Logan RFA. et al. Mortality from acute upper gastrointestinal bleeding in the United Kingdom: does it display a “weekend effect”?. Am J Gastroenterol 2011; 106: 1621-1628
• 8 Smart HL, Langman MJ. Late outcome of bleeding gastric ulcers. Gut 1986; 27: 926-928
• 9 Sung JJY, Tsoi KKF, Ma TKW. et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010; 105: 84-89
• 10 Nuttall M, Meulen JVD, Emberton M. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 2006; 59: 265-273
• 11 Mortality team, Life Events and Population Sources Division, Office for National Statistics. Sex-specific Age-standardised rates for Deaths from Stroke, Ischaemic heart disease, Peripheral vascular disease and Acute vascular disorders of intestine, England, 2001–2013. Reference number 004058. Available at (Accessed 30 November 2020): http://www.ons.gov.uk/ons/about-ons/business-transparency/freedom-of-information/what-can-i-request/published-ad-hoc-data/health/april-2015/index.html
• 12 Calvet X, Vergara M, Brullet E. et al. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. Gastroenterology 2004; 126: 441-450
• 13 Marmo R, Rotondano G, Piscopo R. et al. Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007; 102: 279-289
• 14 Jairath V, Hearnshaw S, Brunskill SJ. et al. Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev 2010; CD006613
• 15 Hearnshaw SA, Logan RFA, Palmer KR. et al. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010; 32: 215-224
• 16 Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI. et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010; CD002907
• 17 Acute upper gastrointestinal bleeding in over 16s: management [CG141] Published June 2012. Last updated 2016. Available at (Accessed 30 November 2020): https://www.nice.org.uk/guidance/cg141
• 18 Gralnek IM, Dumonceau J, Kuipers EJ. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 1-46
• 19 Button LA, Roberts SE, Evans PA. et al. Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. Aliment Pharmacol Ther 2010; 33: 64-76
• 20 Lanas A, García-Rodríguez LA, Polo-Tomás M. et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009; 104: 1633-1641
• 21 Loperfido S, Baldo V, Piovesana E. et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 2009; 70: 212-224
• 22 Fiore FD, Lecleire S, Merle V. et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol 2005; 17: 641-647
• 23 Leerdam MM, Vreeburg EM, Rauws EM. et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98: 1494-1499
• 24 McCormick PA. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-685
• 25 Jairath V, Kakan BC, Logan RF. et al. Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy 2012; 44: 723-730
• 26 Targownik LE, Nabalamba A. Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993–2003. Clin Gastroenterol Hepatol 2006; 4: 1459-1466
• 27 Clarke M, Bunting D, Smart N. et al. The surgical management of acute upper gastrointestinal bleeding: A 12-year experience. Int J Surg 2010; 8: 377-380
• 28 Wong TC, Wong K-T, Chiu PW. et al. A comparison of angiographic embolization with surgery after failed endoscopic hemostasis to bleeding peptic ulcers. Gastrointest Endosc 2011; 73: 900-908
• 29 Laine L. Review article: gastrointestinal bleeding with low-dose aspirin – what’s the risk?. Aliment Pharmacol Ther 2006; 24: 897-908
• 30 Hallas J, Dall M, Andries A. et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006; 333: 726
• 31 Cheung J, Rajala J, Moroz D. et al. Acetylsalicylic acid use in patients with acute myocardial infarction and peptic ulcer bleeding. Can J Gastroenterol 2009; 23: 619-623
• 32 Derogar M, Sandblom G, Lundell L. et al. Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol 2013; 11: 38-42
• 33 Sung JJ, Lau JY, Ching JY. et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding. Ann Intern Med 2010; 152: 1-9
• 34 Barkun AN, Bardou M, Kuipers EJ. et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-13
• 35 Health and Social Care Information Centre. The Quality of Nationally Submitted Health and Social Care Data England, Annual Report, 2013, Experimental Statistics. Available at (Accessed 30 November 2020): https://files.digital.nhs.uk/publicationimport/pub11xxx/pub11530/second-annu-data-qual-rep-2013.pdf